Clinical Research Directory
Browse clinical research sites, groups, and studies.
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
Sponsor: University of Utah
Summary
This goal of this observational study is to develop and test the Opioid Risk Reduction Clinical Decision Support (ORRCDS) tool. The tool will be an opioid medication risk screener and decision support platform that will be used by pharmacists upon dispensing prescription opioid medication. Once the Opioid Risk Reduction has been developed, we will examine the impact of the ORRCDS within two divisions of a large chain retail pharmacy. Pharmacies will be randomized to using the Opioid Risk Reduction Clinical Decision Support (ORRCDS) tool or standard of care opioid dispensation. We hypothesize that patients at pharmacies randomized to the ORRCDS tool will be more likely to reduce their risk status to low or moderate compared to the patients at standard of care pharmacies.
Official title: Adaption and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool (PharmTool)
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2025-01-21
Completion Date
2026-05-15
Last Updated
2026-02-17
Healthy Volunteers
Yes
Conditions
Interventions
Clinical Decision Support Tool (Moderate Risk)
Moderate risk patients will get brief motivational intervention for medication misuse and an offer of naloxone dispensation.
Clinical Decision Support Tool (High Risk)
Those with high risk will receive a brief motivational intervention leading to warm handoff treatment linkage intervention to primary or specialty substance use care with an offer for naloxone dispensation.
Standard of Care
Ohio State law requires pharmacist to not dispense an opioid supply \>90 days, with a specific prohibition on dispensations ≥14 days after prescriptions are issued. Pharmacists are also required to perform a universal prescription drug medication review before initial dispensation and offer brief counseling (e.g., unstandardized information about medication safety) for new/modified prescription therapies.
Locations (2)
University of Cincinnati
Cincinnati, Ohio, United States
University of Utah
Salt Lake City, Utah, United States